Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda Grants License To Neurocrine Biosciences For Seven Pipeline Programs
NASDAQ
Tue, 06/16/20 - 10:48 am
Takeda
Neurocrine Biosciences
psychiatry
schizophrenia
treatment-resistant depression
anhedonia
Takeda-partnered Shattuck nabs mighty $118M funding round for immunotherapy, autoimmune work
Fierce Biotech
Mon, 06/15/20 - 10:33 am
Takeda
Shattuck
funding
drug development
Takeda continues post-Shire selloff, inching closer to $10B goal
Endpoints
Thu, 06/11/20 - 12:16 pm
Takeda
Celltrion
M&A
Shire
South Korea
Shiny new startup Egle grabs a deal with Takeda for cancer research
Fierce Biotech
Thu, 06/11/20 - 11:08 am
Egle Therapeutics
Takeda
R&D
Once a gem, now just a rock, Takeda punts PhIII IBD drug as rivals muscle ahead
Endpoints
Fri, 05/29/20 - 10:45 am
Takeda
IBD
SHP647
Shire
Takeda posts surprise profit a year after Shire mega-merger
Pharmaforum
Wed, 05/13/20 - 10:52 am
Japan
Takeda
Shire
M&A
earnings
Roche’s test of novel gut target nears
EP Vantage
Tue, 05/12/20 - 11:39 am
Roche
ulcerative colitis
etrolizumab
Takeda
Entyvio
Ovid's lead drug shows promising efficacy signal in Fragile X syndrome study, but optimal dosing regimen is unclear for path forward
Endpoints
Fri, 05/8/20 - 10:34 am
Ovid Therapeutics
Takeda
Lundbeck
Fragile X syndrome
clinical trials
Takeda gets FDA breakthrough therapy status for mobocertinib to treat certain type of lung cancer
Pharmaceutical Business Review
Tue, 04/28/20 - 11:45 pm
Takeda
FDA
mobocertinib
metastatic non-small cell lung cancer
Takeda licenses ProThera plasma drug for use in inflammatory conditions
Fierce Biotech
Fri, 04/24/20 - 11:07 am
Takeda
ProThera Biologics
inflammatory diseases
plasma-based pharmaceuticals
Takeda to sell European OTC business to cut debts
Pharmaforum
Fri, 04/24/20 - 10:53 am
Takeda
Europe
debt
OTC
Takeda, CSL forge coronavirus alliance, forgoing their own drugs in the process
BioPharma Dive
Wed, 04/8/20 - 10:33 am
Takeda
CSL
COVID-19
plasma
drug development
Biopharma acquisitions slow, but it's not Covid-19's fault yet
EP Vantage
Wed, 04/8/20 - 10:28 am
M&A
COVID-19
Gilead Sciences
Forty Seven
Eli Lilly
Dermira
Takeda
Hypera Pharma
ANI Pharmaceuticals
Amerigen Pharma
Takeda and Evotec Enter into Gene Therapy Research Alliance
BioSpace
Mon, 04/6/20 - 09:43 pm
Takeda
Evotec
gene therapy
R&D
Takeda signs $882m rare disease alliance with Oxford biotech Evox
Pharmaforum
Fri, 03/27/20 - 10:34 am
Evox Therapeutics
Takeda
Rare Diseases
biotech
Bayer inks up with “small” Indian biotech for new approach at an old target
Endpoints
Mon, 03/23/20 - 11:31 am
Bayer
Curadev
Takeda
R&D
India
2 newer multiple myeloma drugs fall short in bid for wider market
BioPharma Dive
Tue, 03/10/20 - 11:58 am
Multiple Myeloma
clinical trials
Bristol-Myers Squibb
Takeda
Ninlaro
Empliciti
Revlimid
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
Marketwatch
Sun, 03/8/20 - 11:26 pm
Gilead Sciences
GSK
Innovio
JNJ
Moderna Therapeutics
Regeneron
Sanofi
Takeda
Vir Biotchnology
Takeda and Arcturus join hunt for coronavirus therapies
Pharmaforum
Thu, 03/5/20 - 10:50 am
Takeda
Arcturus
COVID-19
coronavirus
drug development
Can reformulation of an AstraZeneca castoff rival Takeda's new heartburn drug? Here's a $26M bet on yes
Endpoints
Wed, 03/4/20 - 07:55 pm
Cinclus Pharma
AstraZeneca
heartburn
linaprazan
Takeda
acid reflux
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »